PREFER webinar 26 April on the value of patient preferences in the medical product life cycle
What is a patient preference and what is the difference between a preference and patient reported outcomes? Join us on 26 April in a webinar to listen and discuss. We will talk about the actors in the medicinal product life cycle and how they can benefit from patient preference studies, and explain what we mean by patient preference sensitive situations.
Presenters include Isabelle Huys from KU Leuven, who will set the scene for presentations the value of patient preference studies for different stakeholders. Mireille Mueller from Novartis and Monika Brand from JNJ will explain the role this input can have in regulatory decision making. Irina Cleemput from the Belgian HTA authority KCE will talk about the value in decision making for health technology assessors and payers. The webinar ends with a presentation by Rosanne Janssens from KU Leuven on stakeholder needs.
Join us on 26 April at 16:30 CEST! Can't be there? The webinar will be recorded and shared on the PREFER YouTube channel.
This is the first in a series of webinars from PREFER. Want to know more? We suggest you sign up to our newsletter (Link removed) to ensure you are notified!